Dilbir S. Bindra,Jatin M. Patel,Li tao,Mandar V. Dali,Nipa Vatsaraj,PRAKASH V. PARAB,Ravindra W. Tejwani,Yongmei Wu
申请号：
BRPI0809233
公开号：
BRPI0809233B1
申请日:
2008.03.21
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
Pharmaceutical formulations are provided which are in the form of capsules or tablets for oral use and which include dapagliflozin propylene glycol hydrate is: Formula (Ia) or Formula (Ib) and a pharmaceutical acceptable carrier therefore, which formulation is designed for immediate release. The formulations are used for the treatment of diabetes and related diseases.
